A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain

Conditions: Pain Interventions: Drug: Voltaren Gel 1% (diclofenac sodium) (US only); Drug: Voltaren Gel 1.16% (diclofenac diethylammonium) (EU only); Drug: Voltaren Gel 2.32% (diclofenac diethylammonium) (EU only) Sponsors: HALEON Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials